Yes, preventive GYN exams are facing high rejection rates from payers—with OBGYN practices collecting $1M–$5M+ monthly experiencing 32–48% denial rates on routine pelvic examinations and annual Pap tests because recent USPSTF guidelines classify screening pelvic exams in asymptomatic women as having insufficient evidence for benefit, prompting commercial insurers to deny claims as “not medically necessary” […]
Are Preventive GYN Exams Facing High Rejection Rates From Payers?









